INGR director moves 278 shares into Cafedan trust; holdings listed

Rhea-AI Filing Summary

On 10/10/2025, director Jorge A. Uribe reported transfers involving Ingredion Inc. (INGR) common stock. He transferred 278 directly owned shares to the Cafedan Investments Ltd Trust, of which he is trustee and his children are beneficiaries. After the reported transactions the filing shows 12,744.9806 shares owned directly and 5,937 shares held indirectly through the trust. The filing was submitted on a Form 4 under Section 16 and was signed by an attorney-in-fact on behalf of the reporting person.

Insider Trade Summary

Net Seller: 556 shares

Net Sell 2 txns

Insider Uribe Jorge A.

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	278	$0.00	$0.00
Gift	Common Stock	278	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,744.9806 shares (Direct); Common Stock — 5,937 shares (Indirect, Through Cafedan Investments Ltd Trust)

Footnotes (1)

1. F1. On October 10, 2025, the reporting person transferred 278 directly owned shares of Ingredion Common Stock to the Cafedan Investments Ltd Trust, of which the insider is the trustee and his children are the beneficiaries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 10/10/2025 - 12:00 PM Learn about SEC filing dates

FAQ

What transaction did Jorge A. Uribe report on Form 4 for INGR?

He transferred 278 shares of Ingredion common stock to the Cafedan Investments Ltd Trust on 10/10/2025.

How many Ingredion shares does Jorge A. Uribe own after the reported transactions?

The filing shows 12,744.9806 shares owned directly and 5,937 shares indirectly through the trust following the transactions.

What is the relationship between Jorge A. Uribe and the Cafedan Investments Ltd Trust?

The filing states he is the trustee of Cafedan Investments Ltd Trust and his children are the beneficiaries.

Was any cash consideration reported for the transferred shares?

No price or cash consideration is reported; the transfer of 278 shares is recorded with a price of $0 in the Form 4.

Who signed the Form 4 filing for Jorge A. Uribe?

The Form 4 was signed by Michael N. Levy, attorney-in-fact on 10/10/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Uribe Jorge A.

(Last) (First) (Middle)

5 WESTBROOK CORPORATE CENTER

(Street)

WESTCHESTER IL 60154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ingredion Inc [ INGR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/10/2025		G	V	278	D	$0	12,744.9806	D
Common Stock	10/10/2025		G	V	278	A	$0	5,937(1)	I	Through Cafedan Investments Ltd Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On October 10, 2025, the reporting person transferred 278 directly owned shares of Ingredion Common Stock to the Cafedan Investments Ltd Trust, of which the insider is the trustee and his children are the beneficiaries.

	Michael N. Levy, attorney-in-fact	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.